Biology Reference
In-Depth Information
transduction does not alter disease progression
in fALS mice. Mol Ther 16:1018-1025
42. Storek B, Reinhardt M, Wang C, Janssen WG,
Harder NM, Banck MS, Morrison JH, Beutler
AS (2008) Sensory neuron targeting by self-
complementary AAV8 via lumbar puncture for
chronic pain. Proc Natl Acad Sci USA 105:
1055-1060
43. Cearley CN, Vandenberghe LH, Parente MK,
Carnish ER, Wilson JM, Wolfe JH (2008)
Expanded repertoire of AAV vector serotypes
mediate unique patterns of transduction in
mouse brain. Mol Ther 16:1710-1718
44. Lawlor PA, Bland RJ, Mouravlev A, Young D,
During MJ (2009) Effi cient gene delivery
and selective transduction of glial cells in the
mammalian brain by AAV serotypes isolated
from nonhuman primates. Mol Ther 17:
1692-1702
45. Shevtsova Z, Malik JM, Michel U, Bahr M,
Kugler S (2005) Promoters and serotypes: tar-
geting of adeno-associated virus vectors for
gene transfer in the rat central nervous system
in vitro and in vivo. Exp Physiol 90:53-59
46. Kugler S, Lingor P, Scholl U, Zolotukhin S,
Bahr M (2003) Differential transgene expres-
sion in brain cells in vivo and in vitro from
AAV-2 vectors with small transcriptional con-
trol units. Virology 311:89-95
47. Brown BD, Gentner B, Cantore A, Colleoni S,
Amendola M, Zingale A, Baccarini A, Lazzari
G, Galli C, Naldini L (2007) Endogenous
microRNA can be broadly exploited to regu-
late transgene expression according to tissue,
lineage and differentiation state. Nat
Biotechnol 25:1457-1467
48. Lock M, McGorray S, Auricchio A, Ayuso E,
Beecham EJ, Blouin-Tavel V, Bosch F, Bose
M, Byrne BJ, Caton T, Chiorini JA, Chtarto A,
Clark KR, Conlon T, Darmon C, Doria M,
Douar A, Flotte TR, Francis JD, Francois A,
Giacca M, Korn MT, Korytov I, Leon X,
Leuchs B, Lux G, Melas C, Mizukami H,
Moullier P, Muller M, Ozawa K, Philipsberg
T, Poulard K, Raupp C, Riviere C, Roosendaal
SD, Samulski RJ, Soltys SM, Surosky R,
Tenenbaum L, Thomas DL, van Montfort B,
Veres G, Wright JF, Xu Y, Zelenaia O, Zentilin
L, Snyder RO (2010) Characterization of a
recombinant adeno-associated virus type 2 ref-
erence standard material. Hum Gene Ther
21:1273-1285
49. Rohr UP, Heyd F, Neukirchen J, Wulf MA,
Queitsch I, Kroener-Lux G, Steidl U, Fenk R,
Haas R, Kronenwett R (2005) Quantitative
real-time PCR for titration of infectious
recombinant AAV-2 particles. J Virol Methods
127:40-45
50. Aurnhammer C, Haase M, Muether N, Hausl
M, Rauschhuber C, Huber I, Nitschko H,
Busch U, Sing A, Ehrhardt A, Baiker A (2011)
Universal real-time PCR for the detection and
quantifi cation of adeno-associated virus sero-
type 2-derived inverted terminal repeat
sequences. Hum Gene Ther 23:18-28
51. Vandenberghe LH, Xiao R, Lock M, Lin J,
Korn M, Wilson JM (2010) Effi cient serotype-
dependent release of functional vector into
the culture medium during adeno-associated
virus manufacturing. Hum Gene Ther 21:
1251-1257
52. Zeltner N, Kohlbrenner E, Clement N, Weber
T, Linden RM (2010) Near-perfect infectivity
of wild-type AAV as benchmark for infectivity
of recombinant AAV vectors. Gene Ther
17:872-879
Search WWH ::
Custom Search